Acute Coronary Syndrome, Drug Therapy
Conditions
Brief summary
Registry Study on Drug Therapy and Clinical Outcomes in Patients With Acute Coronary Syndrome
Interventions
None listed
Sponsors
Beijing Anzhen Hospital
Study design
Observational model
OTHER
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Informed consent has been signed. * Patients diagnosed in our hospital with acute coronary syndrome. * Age ≥18. * Life expectancy ≥12 months.
Exclusion criteria
* Severe lack of important information such as history of previous medication, history of previous disease, history of surgery. * Pregnant and lactating women. * Mental disorders, or inability to communicate effectively with researchers, or failure to comply with research protocols.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| main adverse cardiovascular and cerebrovascular events (MACCE) | up to 5 years | MACCE will be defined as all-cause death, non-fatal stroke, non-fatal myocardial infarction (MI), and ischemic-driven revascularization. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Adverse drug reaction | up to 5 years | Adverse drug reaction will be defined as any adverse reactions in the patients. |
Countries
China
Contacts
Primary ContactYi Zhang, PhD
Backup ContactYang Lin, PhD
Outcome results
None listed